1 of 1
Story summary
- A Nature study by Mass General Brigham and Fudan University reports that a gene therapy targeting the OTOF gene restored significant hearing in 90% of 42 participants within weeks.
- The therapy was delivered via a harmless virus and produced lasting improvements noted for over two years.
- Researchers say the treatment could enable speech development and plan to explore its application for other types of hearing loss.
